tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BAYRY Stock Latest News

Bayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
Company AnnouncementsBayer and Daiichi Sankyo Advance New Prostate Cancer Combo in Early-Stage Trial
9h ago
Bayer’s VERI‑China Heart Failure Study Nears Readout: What Investors Should Watch
PremiumCompany Announcements
Bayer’s VERI‑China Heart Failure Study Nears Readout: What Investors Should Watch
5d ago
BAYRY
Bayer investing over C$45M to build canola research, development facility
PremiumThe Fly
Bayer investing over C$45M to build canola research, development facility
8d ago
Bayer’s ROAD Study Targets Real-World Upside for Nubeqa in Advanced Prostate Cancer
PremiumCompany Announcements
Bayer’s ROAD Study Targets Real-World Upside for Nubeqa in Advanced Prostate Cancer
9d ago
BAYRY
Bayer and Guerbet Advance Long-Term Gadolinium Safety Study, Keeping MRI Contrast Risk in Focus
PremiumCompany Announcements
Bayer and Guerbet Advance Long-Term Gadolinium Safety Study, Keeping MRI Contrast Risk in Focus
13d ago
Bayer Maps Sepsis-Related Clotting Risks in Japan, Sharpening Its Critical Care Strategy
PremiumCompany AnnouncementsBayer Maps Sepsis-Related Clotting Risks in Japan, Sharpening Its Critical Care Strategy
14d ago
BAYRY
Bayer, Vanderbilt University Medical Center enter five-year collaboration
Premium
The Fly
Bayer, Vanderbilt University Medical Center enter five-year collaboration
16d ago
Bayer Stock Soars as U.S. Supreme Court Agrees to Review Roundup Appeal
Premium
Market News
Bayer Stock Soars as U.S. Supreme Court Agrees to Review Roundup Appeal
17d ago
Bayer ‘welcomes’ Supreme Court review of Durnell litigation
PremiumThe Fly
Bayer ‘welcomes’ Supreme Court review of Durnell litigation
19d ago
U.S. Supreme Court to hear Bayer’s appeal of Roundup lawsuits, Bloomberg says
PremiumThe Fly
U.S. Supreme Court to hear Bayer’s appeal of Roundup lawsuits, Bloomberg says
19d ago
Bayer to acquire AT-01 and AT-05 from Attralus, terms undisclosed
PremiumThe Fly
Bayer to acquire AT-01 and AT-05 from Attralus, terms undisclosed
24d ago
Bayer’s New Phase 4 ATTR-CM Study Tests Switching From Tafamidis to Acoramidis
PremiumCompany Announcements
Bayer’s New Phase 4 ATTR-CM Study Tests Switching From Tafamidis to Acoramidis
26d ago
BAYRY
Bayer’s FINE-REAL Korea Study Tracks Real-World Use of Finerenone in Diabetic Kidney Disease
PremiumCompany AnnouncementsBayer’s FINE-REAL Korea Study Tracks Real-World Use of Finerenone in Diabetic Kidney Disease
26d ago
BAYRY
Bayer’s New Parkinson’s Study Builds a Long-Term Data Edge, Not Near-Term Profits
Premium
Company Announcements
Bayer’s New Parkinson’s Study Builds a Long-Term Data Edge, Not Near-Term Profits
26d ago
BAYRY
Bayer, Souffle Therapeutics report global licensing agreement for siRNA therapy
Premium
The Fly
Bayer, Souffle Therapeutics report global licensing agreement for siRNA therapy
28d ago
Bayer’s BAY3018250 DVT Study Reaches Completion: What It Means for Investors
PremiumCompany Announcements
Bayer’s BAY3018250 DVT Study Reaches Completion: What It Means for Investors
28d ago
BAYRY
Barclays upgrades Bayer to Overweight on possible litigation overhang resolution
PremiumThe Fly
Barclays upgrades Bayer to Overweight on possible litigation overhang resolution
29d ago
Bayer upgraded to Overweight from Equal Weight at Barclays
PremiumThe Fly
Bayer upgraded to Overweight from Equal Weight at Barclays
29d ago
Bayer added to European Conviction List at Goldman Sachs
PremiumThe Fly
Bayer added to European Conviction List at Goldman Sachs
1M ago
Bayer Tests Talcid in Real-World Acid Rebound Study: What It Means for BAYRY Investors
PremiumCompany AnnouncementsBayer Tests Talcid in Real-World Acid Rebound Study: What It Means for BAYRY Investors
1M ago
BAYRY
Bayer Backs AskBio Gene Therapy Push in Pompe Disease: Early Trial Update and Investor Takeaways
Premium
Company Announcements
Bayer Backs AskBio Gene Therapy Push in Pompe Disease: Early Trial Update and Investor Takeaways
2M ago
BAYRY
Bayer price target raised to EUR 41 from EUR 30.40 at Berenberg
Premium
The Fly
Bayer price target raised to EUR 41 from EUR 30.40 at Berenberg
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >